Dr. Michael Helmrath, MD and Jim Wells, PhD of the Cincinnati Children’s Hospital Medical Center announced a significant advance in the differentiation of pluripotent stem cells into intestinal tissue with functional nerves. This milestone will enable the use of the cultured intestinal tissue to be used, in the short term, for drug testing and, in the longer term, for the development of regenerative treatments to address a myriad of intestinal disorders such as Irritable Bowel Syndrome, Intestinal Cancers and Hirschsprung’s disease.
According to Dr. Michael Helmrath, surgical director of the Intestinal Rehabilitation Program at the Cincinnati Children's Hospital Medical Center, "One day this technology will allow us to grow a section of healthy intestine for transplant into a patient, but the ability to use it now to test and ask countless new questions will help human health to the greatest extent,"
As regenerative engineering progresses, we believe the best stem cells to use in emerging treatments will be the patient’s own [autologous stem cells] as this negates the need to find a suitable donor and eliminates the chances of rejection of the transplanted tissue. To learn more about banking your own valuable stem cells to insure your family’s future health, visit StemSave or call 877-783-6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.